National Blood Sector Research and Development Program – Round 6

Overview

The National Blood Sector Research and Development Program (the Program) forms an important component of the National Blood Authority’s (NBA) blood sector research and development framework and aims to facilitate world-class research and development in Australia that contributes to optimising the use, management and administration of blood products, and improve patient outcomes. The Program is focussed on the following research areas: Patient Blood Management (PBM) evidence gaps. Efficient and effective use of immunoglobulin (Ig) products. The Program will also use the new National Blood Research and Development Strategic Priorities 2022-27 to provide focus and scope for funded research. The criteria used to assess applications received for Round 6 of the Program will include how well the proposed project addresses topics included in the Strategic Priorities 2022-27. Up to $1.275 million is available under Round 6 of the Program for single or multiple year projects. Grants are offered under 3 categories: Project Grants, typically $30,000 to $150,000 per year to be expended over a period of up to 3 years. Applications should be for an entire, discrete research project proposal. Seed Grants, typically under $50,000 to be expended over 1 year. Applications for seed funding should be for early stages of innovative new research, or for effort generation of preliminary data needed to support future grant applications. Scholarships, typically $25,000 to $30,000 to be expended over 1 year. Scholarship grants are intended to support medical researchers in the attainment of a PhD or Master’s degree or postdoctoral research fellow research. Application forms are available on the NBA Website at   https://www.blood.gov.au/data-and-research/research-funding-program Applications will be assessed based on: Research scope, focus and potential value Quality Governance and ethics Efficient and effective use of funds.